Corient Private Wealth LLC Has $2 Million Holdings in Envista Holdings Corporation $NVST

Corient Private Wealth LLC lifted its position in Envista Holdings Corporation (NYSE:NVST) by 311.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 92,259 shares of the company’s stock after acquiring an additional 69,820 shares during the period. Corient Private Wealth LLC’s holdings in Envista were worth $2,003,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd raised its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares in the last quarter. Allworth Financial LP grew its position in shares of Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. UMB Bank n.a. grew its position in shares of Envista by 46.1% in the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares during the period. IFP Advisors Inc increased its stake in shares of Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after purchasing an additional 1,071 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after purchasing an additional 949 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on NVST. Citigroup initiated coverage on shares of Envista in a report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 target price on the stock. Evercore reissued an “outperform” rating and set a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. Weiss Ratings downgraded Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. JPMorgan Chase & Co. upped their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Barclays cut their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, June 11th. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Envista currently has an average rating of “Hold” and a consensus price target of $28.67.

Envista Price Performance

Shares of NVST opened at $26.97 on Tuesday. The firm has a market capitalization of $4.39 billion, a PE ratio of 65.78, a PEG ratio of 1.53 and a beta of 0.88. The company’s 50-day moving average is $24.88 and its 200-day moving average is $25.15. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The company had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts forecast that Envista Holdings Corporation will post 1.42 EPS for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.